208 related articles for article (PubMed ID: 1676673)
21. HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor.
Lee J; Dull TJ; Lax I; Schlessinger J; Ullrich A
EMBO J; 1989 Jan; 8(1):167-73. PubMed ID: 2565808
[TBL] [Abstract][Full Text] [Related]
22. c-Cbl is a suppressor of the neu oncogene.
Levkowitz G; Oved S; Klapper LN; Harari D; Lavi S; Sela M; Yarden Y
J Biol Chem; 2000 Nov; 275(45):35532-9. PubMed ID: 10940298
[TBL] [Abstract][Full Text] [Related]
23. Ligand-independent tyrosine phosphorylation of the receptor encoded by the c-neu oncogene.
Boccaccio C; Gaudino G; Cilli M; Mondino A; Comoglio PM
Growth Factors; 1991; 5(3):233-42. PubMed ID: 1685656
[TBL] [Abstract][Full Text] [Related]
24. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1.
Mohammadi M; Honegger AM; Rotin D; Fischer R; Bellot F; Li W; Dionne CA; Jaye M; Rubinstein M; Schlessinger J
Mol Cell Biol; 1991 Oct; 11(10):5068-78. PubMed ID: 1656221
[TBL] [Abstract][Full Text] [Related]
25. Phospholipase C-gamma 1 directly associates with the p70 trk oncogene product through its src homology domains.
Ohmichi M; Decker SJ; Pang L; Saltiel AR
J Biol Chem; 1991 Aug; 266(23):14858-61. PubMed ID: 1831195
[TBL] [Abstract][Full Text] [Related]
26. Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active.
Yarden Y
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2569-73. PubMed ID: 1969636
[TBL] [Abstract][Full Text] [Related]
27. In vitro tyrosine phosphorylation of PLC-gamma 1 and PLC-gamma 2 by src-family protein tyrosine kinases.
Liao F; Shin HS; Rhee SG
Biochem Biophys Res Commun; 1993 Mar; 191(3):1028-33. PubMed ID: 7682059
[TBL] [Abstract][Full Text] [Related]
28. Tyrosine kinase activity is essential for the association of phospholipase C-gamma with the epidermal growth factor receptor.
Margolis B; Bellot F; Honegger AM; Ullrich A; Schlessinger J; Zilberstein A
Mol Cell Biol; 1990 Feb; 10(2):435-41. PubMed ID: 2153914
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
[TBL] [Abstract][Full Text] [Related]
30. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells.
Cross MJ; Lu L; Magnusson P; Nyqvist D; Holmqvist K; Welsh M; Claesson-Welsh L
Mol Biol Cell; 2002 Aug; 13(8):2881-93. PubMed ID: 12181353
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor activates phospholipase C in rat hepatocytes via a different mechanism from that in A431 or rat1hER cells.
Liang M; Garrison JC
Mol Pharmacol; 1992 Nov; 42(5):743-52. PubMed ID: 1435749
[TBL] [Abstract][Full Text] [Related]
32. A subdomain in the transmembrane domain is necessary for p185neu* activation.
Cao H; Bangalore L; Bormann BJ; Stern DF
EMBO J; 1992 Mar; 11(3):923-32. PubMed ID: 1347745
[TBL] [Abstract][Full Text] [Related]
33. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis.
Mohammadi M; Dionne CA; Li W; Li N; Spivak T; Honegger AM; Jaye M; Schlessinger J
Nature; 1992 Aug; 358(6388):681-4. PubMed ID: 1379698
[TBL] [Abstract][Full Text] [Related]
34. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.
Law CL; Sidorenko SP; Chandran KA; Zhao Z; Shen SH; Fischer EH; Clark EA
J Exp Med; 1996 Feb; 183(2):547-60. PubMed ID: 8627166
[TBL] [Abstract][Full Text] [Related]
35. Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis.
Peters KG; Marie J; Wilson E; Ives HE; Escobedo J; Del Rosario M; Mirda D; Williams LT
Nature; 1992 Aug; 358(6388):678-81. PubMed ID: 1379697
[TBL] [Abstract][Full Text] [Related]
36. Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro.
Meisenhelder J; Suh PG; Rhee SG; Hunter T
Cell; 1989 Jun; 57(7):1109-22. PubMed ID: 2472219
[TBL] [Abstract][Full Text] [Related]
37. Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein.
Weiner DB; Kokai Y; Wada T; Cohen JA; Williams WV; Greene MI
Oncogene; 1989 Oct; 4(10):1175-83. PubMed ID: 2571965
[TBL] [Abstract][Full Text] [Related]
38. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
Stern DF; Heffernan PA; Weinberg RA
Mol Cell Biol; 1986 May; 6(5):1729-40. PubMed ID: 2878363
[TBL] [Abstract][Full Text] [Related]
39. Phospholipase C-gamma 1 associates with viral and cellular src kinases.
Nakanishi O; Shibasaki F; Hidaka M; Homma Y; Takenawa T
J Biol Chem; 1993 May; 268(15):10754-9. PubMed ID: 8388373
[TBL] [Abstract][Full Text] [Related]
40. Phospholipase C-gamma1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk.
Law CL; Chandran KA; Sidorenko SP; Clark EA
Mol Cell Biol; 1996 Apr; 16(4):1305-15. PubMed ID: 8657103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
